Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 571 AL 585

Impaired intracellular trafficking defines early Parkinson's disease

Hunn BH, Cragg SJ, Bolam JP, Spillantini MG, Wade-Martins R.

Trends Neurosci. 2015 Mar;38(3):178-88. doi: 10.1016/j.tins.2014.12.009. Epub 2015 Jan 29.

Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control

Lee SM, Kim M, Lee HM, Kwon KY, Koh SB.

J Neurol Sci. 2015 Feb 15;349(1-2):168-73. doi: 10.1016/j.jns.2015.01.012. Epub 2015 Jan 13.

Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases

Victoria GS, Zurzolo C.

Virus Res. 2015 Sep 2;207:146-54. doi: 10.1016/j.virusres.2015.01.019. Epub 2015 Jan 30.

Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors

Seeman P.

Synapse. 2015 Apr;69(4):183-9. doi: 10.1002/syn.21805. Epub 2015 Feb 3.

A visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology

Porras P, Duesbury M, Fabregat A, Ueffing M, Orchard S, Gloeckner CJ, Hermjakob H.

Proteomics. 2015 Apr;15(8):1390-404. doi: 10.1002/pmic.201400390. Epub 2015 Mar 21.

Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease

Carboni E, Lingor P.

Metallomics. 2015 Mar;7(3):395-404. doi: 10.1039/c4mt00339j.

Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease

Ferreira JJ, Rocha JF, Falcão A, Santos A, Pinto R, Nunes T, Soares-da-Silva P.

Eur J Neurol. 2015 May;22(5):815-25, e56. doi: 10.1111/ene.12666. Epub 2015 Feb 4.

A Meta-Analysis on the Efficacy of Tai Chi in Patients with Parkinson's Disease between 2008 and 2014

Zhou J, Yin T, Gao Q, Yang XC.

Evid Based Complement Alternat Med. 2015;2015:593263. doi: 10.1155/2015/593263. Epub 2015 Jan 8.

The Rationale for Exercise in the Management of Pain in Parkinson's Disease

Allen NE, Moloney N, van Vliet V, Canning CG.

J Parkinsons Dis. 2015;5(2):229-39. doi: 10.3233/JPD-140508.

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

Pahwa R, Tanner CM, Hauser RA, Sethi K, Isaacson S, Truong D, Struck L, Ruby AE, McClure NL, Went GT, Stempien MJ.

Mov Disord. 2015 May;30(6):788-95. doi: 10.1002/mds.26159. Epub 2015 Feb 4.

Deep brain stimulation for Parkinson disease in Australia: current scientific and clinical status

Poortvliet PC, Silburn PA, Coyne TJ, Chenery HJ.

Intern Med J. 2015 Feb;45(2):134-9. doi: 10.1111/imj.12656.

Comparing interventions and exploring neural mechanisms of exercise in Parkinson disease: a study protocol for a randomized controlled trial

Earhart GM, Duncan RP, Huang JL, Perlmutter JS, Pickett KA.

BMC Neurol. 2015 Feb 5;15:9. doi: 10.1186/s12883-015-0261-0.

Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits

Philpot RM.

Neurochem Res. 2015 Oct;40(10):2018-31. doi: 10.1007/s11064-015-1528-y. Epub 2015 Feb 5.

The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders

Guan J, Harris P, Brimble M, Lei Y, Lu J, Yang Y, Gunn AJ.

Expert Opin Ther Targets. 2015 Jun;19(6):785-93. doi: 10.1517/14728222.2015.1010514. Epub 2015 Feb 5.

A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice

Arsenault D, Drouin-Ouellet J, Saint-Pierre M, Petrou P, Dubois M, Kriz J, Barker RA, Cicchetti A, Cicchetti F.

J Physiol. 2015 May 15;593(10):2257-78. doi: 10.1113/jphysiol.2014.287243. Epub 2015 Mar 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias